World's Best Scientists 2026 revealed!
Shibo Jiang

Shibo Jiang

Award Badge
Immunology
China
2023

D-Index & Metrics

Medicine

D-Index
115
Citations
50126
World Ranking
4530
National Ranking
42

Shibo Jiang publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Shibo Jiang sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 585 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Shibo Jiang D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Shibo Jiang sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Immunology in China Leader Award
  • 2022 - Research.com Immunology in China Leader Award

Overview

Shibo Jiang is affiliated with Fudan University in China and has contributed extensively to research in the field of medicine, with a specific focus on infectious diseases. Their body of work encompasses related subfields such as animal science and zoology, epidemiology, molecular biology, and immunology.

Their research topics prominently feature SARS-CoV-2 and COVID-19 research, including clinical studies and detection methods. Other notable topics include animal virus infections, viral gastroenteritis research, HIV research and treatment, and drug development for HIV/AIDS.

Frequent co-authors include Lu Lu, Wei Xu, Shuai Xia, Qian Wang, and Zezhong Liu, reflecting a collaborative research environment across multiple studies.

Shibo Jiang has published in several key venues, with multiple contributions to:

  • Signal Transduction and Targeted Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Medical Virology
  • Cell Research
  • Viruses

Selected recent papers demonstrate a focus on coronavirus biology, viral inhibition, and antibody development:

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, 2020, Cellular and Molecular Immunology
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, 2020, Cell Research
  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, 2020, Emerging Microbes & Infections
  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses, 2020, Trends in Immunology
  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, 2020, Science

The scientist has also contributed to book publications, including a title released by Springer Nature:

  • Virus Entry Inhibitors, 2022

Best Publications

  • The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

    Wanbo Tai;Lei He;Xiujuan Zhang;Jing Pu;Jing Pu

  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

    Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu

  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

    Xiaolong Tian;Cheng Li;Ailing Huang;Shuai Xia

  • Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways.

    Yanqing Ding;Li He;Qingling Zhang;Zhongxi Huang

  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

    Shibo Jiang;Shibo Jiang;Christopher Hillyer;Lanying Du

  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

    Hongjing Gu;Qi Chen;Guan Yang;Lei He

  • Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.

    Shuai Xia;Yun Zhu;Meiqin Liu;Qiaoshuai Lan

  • Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

    Fan Wu;Aojie Wang;Mei Liu;Qimin Wang

  • Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

    Shuwen Liu;Gengfu Xiao;Yibang Chen;Yuxian He

  • HIV-1 inhibition by a peptide

    Shibo Jiang;Kang Lin;N. Strick;A. R. Neurath

  • Recent advances in the detection of respiratory virus infection in humans

    Naru Zhang;Lili Wang;Xiaoqian Deng;Ruiying Liang

  • Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.

    Xinling Wang;Wei Xu;Gaowei Hu;Shuai Xia

  • A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    Shuai Xia;Lei Yan;Wei Xu;Anurodh Shankar Agrawal

  • Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

    Lu Lu;Qi. Liu;Yun Zhu;Kwok-Hung Chan

  • Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.

    L He;Y Ding;Q Zhang;X Che

  • AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.

    Shuai Wang;Zongyang Qiu;Zongyang Qiu;Yingnan Hou;Yingnan Hou;Xiya Deng;Xiya Deng

  • Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

    Yuxian He;Yusen Zhou;Shuwen Liu;Zhihua Kou

  • Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

    Fei Yu;Lanying Du;David M. Ojcius;Chungen Pan

  • Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry

    Wenjiao Wu;Richan Li;Xianglian Li;Jian He

Frequent Co-Authors

Lu Lu
Lu Lu Fudan University
Lanying Du
Lanying Du Georgia State University
Shuwen Liu
Shuwen Liu Southern Medical University
Yusen Zhou
Yusen Zhou Zhengzhou University
Yuxian He
Yuxian He Peking Union Medical College Hospital
Tianlei Ying
Tianlei Ying Fudan University
Bo-Jian Zheng
Bo-Jian Zheng University of Hong Kong
Chien Te K. Tseng
Chien Te K. Tseng The University of Texas Medical Branch at Galveston
Dimiter S. Dimitrov
Dimiter S. Dimitrov University of Pittsburgh
Sara Lustigman
Sara Lustigman New York Blood Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to diverse healthcare career options—many of which can be accessed or enhanced through specialized online degrees. For those interested in healthcare leadership or administration, exploring cheapest mha programs online is a practical way to gain management skills while keeping tuition affordable.

Nurses seeking advanced practice roles can consider the most affordable online dnp programs, which allow RNs to earn a Doctor of Nursing Practice and meet the high demand for skilled practitioners without interrupting their current careers.

Those fascinated by pharmaceuticals can investigate online pharmacy school cost to discover accessible routes to becoming a Doctor of Pharmacy (PharmD) through flexible, lower-cost online options.

Finally, if managing patient records and health data appeals to you, an online mhi (Master of Health Information Management) program can position you at the intersection of healthcare and technology.

Online degrees offer flexibility, affordability, and a tailored career pathway for those aspiring to excel in many medical and healthcare roles beyond traditional MD programs.

Best Scientists Citing Shibo Jiang

Trending Scientists